<?xml version="1.0" encoding="MacRoman" ?>
<PubmedArticleSet  gate:gateId="0" gate:annotMaxId="276" xmlns:gate="http://www.gate.ac.uk"><PubmedArticle gate:gateId="1"><MedlineCitation gate:gateId="2" Status="MEDLINE" Owner="NLM"><PMID gate:gateId="3" Version="1">20394879</PMID>
        <DateCreated gate:gateId="4">
            <Year gate:gateId="5">2010</Year>
            <Month gate:gateId="6">04</Month>
            <Day gate:gateId="7">16</Day></DateCreated>
        
        <DateCompleted gate:gateId="8">
            <Year gate:gateId="9">2010</Year>
            <Month gate:gateId="10">06</Month>
            <Day gate:gateId="11">15</Day></DateCompleted>
        
        <DateRevised gate:gateId="12">
            <Year gate:gateId="13">2010</Year>
            <Month gate:gateId="14">11</Month>
            <Day gate:gateId="15">18</Day></DateRevised>
        
        <Article gate:gateId="16" PubModel="Print">
            <Journal gate:gateId="17">
                <ISSN gate:gateId="18" IssnType="Electronic">1558-3597</ISSN>
                <JournalIssue gate:gateId="19" CitedMedium="Internet">
                    <Volume gate:gateId="20">55</Volume>
                    <Issue gate:gateId="21">16</Issue>
                    <PubDate gate:gateId="22">
                        <Year gate:gateId="23">2010</Year>
                        <Month gate:gateId="24">Apr</Month>
                        <Day gate:gateId="25">20</Day></PubDate></JournalIssue>
                    
                
                <Title gate:gateId="26">Journal of the American College of Cardiology</Title>
                <ISOAbbreviation gate:gateId="27">J. Am. Coll. Cardiol.</ISOAbbreviation></Journal>
            
            <ArticleTitle gate:gateId="28"><group gate:gateId="249" id="0" role="control">Sirolimus</group> - versus <group gate:gateId="250" id="1" role="experiment">paclitaxel-eluting stents</group> <condition gate:gateId="252" id="0">for the treatment of coronary bifurcations results</condition> : from the COBIS (Coronary Bifurcation Stenting) Registry.</ArticleTitle>
            <Pagination gate:gateId="29">
                <MedlinePgn gate:gateId="30">1743-50</MedlinePgn></Pagination>
            
            <Abstract gate:gateId="31">
                <AbstractText gate:gateId="32" NlmCategory="OBJECTIVE" Label="OBJECTIVES">We aimed to compare the long-term clinical outcomes of <population gate:gateId="253">patients</population> treated with <group gate:gateId="225" id="0" role="control">sirolimus-eluting stents ( <short gate:gateId="227">SES</short> )</group> or <group gate:gateId="226" id="1" role="experiment">paclitaxel-eluting stents ( <short gate:gateId="228">PES</short> )</group> <condition gate:gateId="251" id="0">for coronary bifurcation lesions</condition> .</AbstractText>
                <AbstractText gate:gateId="33" NlmCategory="BACKGROUND" Label="BACKGROUND">There are limited data regarding comparisons of <group gate:gateId="261" id="0" role="control">SES</group> and <group gate:gateId="262" id="1" role="experiment">PES</group> <condition gate:gateId="263" id="0">for the treatment of bifurcation lesions</condition> .</AbstractText>
                <AbstractText gate:gateId="34" NlmCategory="METHODS" Label="METHODS"><population gate:gateId="254">Patients</population> <condition gate:gateId="265" id="1">who received percutaneous coronary intervention</condition> <condition gate:gateId="264" id="0">for non-left main bifurcation lesions</condition> were enrolled from 16 centers in Korea between January 2004 and June 2006. We compared <outcome gate:gateId="270" type="bad" id="0">major adverse cardiac events ( <short gate:gateId="271">MACE</short></outcome> [ <outcome gate:gateId="274" type="bad" id="2">cardiac death</outcome> , <outcome gate:gateId="275" type="bad" id="3">myocardial infarction</outcome> , or <outcome gate:gateId="273" type="bad" id="1">target lesion revascularization</outcome> ]) between the <group gate:gateId="231" id="0" role="control">SES</group> and <group gate:gateId="232" id="1" role="experiment">PES</group> groups in <population gate:gateId="255" safe.regex="true">patients</population> overall and in 407 <population gate:gateId="266">patient</population> pairs generated by propensity-score matching.</AbstractText>
                <AbstractText gate:gateId="35" NlmCategory="RESULTS" Label="RESULTS">We evaluated <gs gate:gateId="235" group="0" time="0">1,033</gs> <population gate:gateId="256" safe.regex="true">patients</population> <condition gate:gateId="229" id="0">with bifurcation lesions</condition> treated with <group gate:gateId="233" id="0" role="control">SES</group> and <gs gate:gateId="236" group="1" time="0">562</gs> <population gate:gateId="257" safe.regex="true">patients</population> treated with <group gate:gateId="234" id="1" role="experiment">PES</group> . The median follow-up duration was <time gate:gateId="269" id="0" units="months">22 months</time> . Treatment with <group gate:gateId="245" id="0" role="control">SES</group> was associated with a lower incidence of <outcome gate:gateId="237" type="bad" id="0">MACE</outcome> (hazard ratio [HR]: 0.53, 95% confidence interval [CI]: 0.32 to 0.89, p &lt; 0.01) and <outcome gate:gateId="238" type="bad" id="1">target lesion revascularization</outcome> (HR: 0.55, 95% CI: 0.31 to 0.97, p = 0.02), but not of <outcome gate:gateId="239" type="bad" id="2">cardiac death</outcome> (HR: 2.77, 95% CI: 0.40 to 18.99, p = 0.62) and <outcome gate:gateId="241" type="bad" id="3">cardiac death or myocardial infarction</outcome> (HR: 0.97, 95% CI: 0.38 to 2.49, p = 0.94). After propensity-score matching, <population gate:gateId="258" safe.regex="true">patients</population> with <group gate:gateId="272" id="0" role="control">SES</group> still had fewer <outcome gate:gateId="246" type="bad" id="0">MACE</outcome> and <outcome gate:gateId="247" type="bad" id="1">target lesion revascularization</outcome> incidences than did <population gate:gateId="259" safe.regex="true">patients</population> with <group gate:gateId="248" id="1" role="experiment">PES</group> (HR: 0.52, 95% CI: 0.30 to 0.91, p = 0.02, and HR: 0.48, 95% CI: 0.25 to 0.91, p = 0.02, respectively). There was no significant difference in the <outcome gate:gateId="240" type="bad" id="4">occurrences of stent thrombosis</outcome> between the groups <eventRate gate:gateId="242" group="0" outcome="4" time="0">(0.7%</eventRate> vs. <eventRate gate:gateId="243" group="1" outcome="4" time="0">0.7%</eventRate> , p = 0.94).</AbstractText>
                <AbstractText gate:gateId="36" NlmCategory="CONCLUSIONS" Label="CONCLUSIONS">In <population gate:gateId="260" safe.regex="true">patients</population> <condition gate:gateId="244" id="0">with bifurcation lesions</condition> , the use of <group gate:gateId="267" id="0" role="control">SES</group> resulted in better long-term outcomes than did the use of <group gate:gateId="268" id="1" role="experiment">PES</group> , primarily by decreasing the rate of repeat revascularization. (Coronary Bifurcation Stenting Registry in South Korea [COBIS]; NCT00851526).</AbstractText>
                <CopyrightInformation gate:gateId="37">Copyright (c) 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract>
            
            <Affiliation gate:gateId="38">Division of Cardiology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.</Affiliation>
            <AuthorList gate:gateId="39" CompleteYN="Y" Type="authors">
                <Author gate:gateId="40" ValidYN="Y">
                    <LastName gate:gateId="41">Song</LastName>
                    <ForeName gate:gateId="42">Young Bin</ForeName>
                    <Initials gate:gateId="43">YB</Initials></Author>
                
                <Author gate:gateId="44" ValidYN="Y">
                    <LastName gate:gateId="45">Hahn</LastName>
                    <ForeName gate:gateId="46">Joo-Yong</ForeName>
                    <Initials gate:gateId="47">JY</Initials></Author>
                
                <Author gate:gateId="48" ValidYN="Y">
                    <LastName gate:gateId="49">Choi</LastName>
                    <ForeName gate:gateId="50">Seung-Hyuk</ForeName>
                    <Initials gate:gateId="51">SH</Initials></Author>
                
                <Author gate:gateId="52" ValidYN="Y">
                    <LastName gate:gateId="53">Choi</LastName>
                    <ForeName gate:gateId="54">Jin-Ho</ForeName>
                    <Initials gate:gateId="55">JH</Initials></Author>
                
                <Author gate:gateId="56" ValidYN="Y">
                    <LastName gate:gateId="57">Lee</LastName>
                    <ForeName gate:gateId="58">Sang Hoon</ForeName>
                    <Initials gate:gateId="59">SH</Initials></Author>
                
                <Author gate:gateId="60" ValidYN="Y">
                    <LastName gate:gateId="61">Jeong</LastName>
                    <ForeName gate:gateId="62">Myung-Ho</ForeName>
                    <Initials gate:gateId="63">MH</Initials></Author>
                
                <Author gate:gateId="64" ValidYN="Y">
                    <LastName gate:gateId="65">Kim</LastName>
                    <ForeName gate:gateId="66">Hyo-Soo</ForeName>
                    <Initials gate:gateId="67">HS</Initials></Author>
                
                <Author gate:gateId="68" ValidYN="Y">
                    <LastName gate:gateId="69">Seong</LastName>
                    <ForeName gate:gateId="70">In-Whan</ForeName>
                    <Initials gate:gateId="71">IW</Initials></Author>
                
                <Author gate:gateId="72" ValidYN="Y">
                    <LastName gate:gateId="73">Yang</LastName>
                    <ForeName gate:gateId="74">Ju-Young</ForeName>
                    <Initials gate:gateId="75">JY</Initials></Author>
                
                <Author gate:gateId="76" ValidYN="Y">
                    <LastName gate:gateId="77">Rha</LastName>
                    <ForeName gate:gateId="78">Seung Woon</ForeName>
                    <Initials gate:gateId="79">SW</Initials></Author>
                
                <Author gate:gateId="80" ValidYN="Y">
                    <LastName gate:gateId="81">Jang</LastName>
                    <ForeName gate:gateId="82">Yangsoo</ForeName>
                    <Initials gate:gateId="83">Y</Initials></Author>
                
                <Author gate:gateId="84" ValidYN="Y">
                    <LastName gate:gateId="85">Yoon</LastName>
                    <ForeName gate:gateId="86">Jung Han</ForeName>
                    <Initials gate:gateId="87">JH</Initials></Author>
                
                <Author gate:gateId="88" ValidYN="Y">
                    <LastName gate:gateId="89">Tahk</LastName>
                    <ForeName gate:gateId="90">Seung-Jea</ForeName>
                    <Initials gate:gateId="91">SJ</Initials></Author>
                
                <Author gate:gateId="92" ValidYN="Y">
                    <LastName gate:gateId="93">Seung</LastName>
                    <ForeName gate:gateId="94">Ki Bae</ForeName>
                    <Initials gate:gateId="95">KB</Initials></Author>
                
                <Author gate:gateId="96" ValidYN="Y">
                    <LastName gate:gateId="97">Park</LastName>
                    <ForeName gate:gateId="98">Seung-Jung</ForeName>
                    <Initials gate:gateId="99">SJ</Initials></Author>
                
                <Author gate:gateId="100" ValidYN="Y">
                    <LastName gate:gateId="101">Gwon</LastName>
                    <ForeName gate:gateId="102">Hyeon-Cheol</ForeName>
                    <Initials gate:gateId="103">HC</Initials></Author></AuthorList>
                
            
            <Language gate:gateId="104">eng</Language>
            <DataBankList gate:gateId="105" CompleteYN="Y">
                <DataBank gate:gateId="106">
                    <DataBankName gate:gateId="107">ClinicalTrials.gov</DataBankName>
                    <AccessionNumberList gate:gateId="108">
                        <AccessionNumber gate:gateId="109">NCT00851526</AccessionNumber></AccessionNumberList></DataBank></DataBankList>
                    
                
            
            <PublicationTypeList gate:gateId="110">
                <PublicationType gate:gateId="111">Comparative Study</PublicationType>
                <PublicationType gate:gateId="112">Journal Article</PublicationType>
                <PublicationType gate:gateId="113">Multicenter Study</PublicationType>
                <PublicationType gate:gateId="114">Randomized Controlled Trial</PublicationType>
                <PublicationType gate:gateId="115">Research Support, Non-U.S. Gov&apos;t</PublicationType></PublicationTypeList></Article>
            
        
        <MedlineJournalInfo gate:gateId="116">
            <Country gate:gateId="117">United States</Country>
            <MedlineTA gate:gateId="118">J Am Coll Cardiol</MedlineTA>
            <NlmUniqueID gate:gateId="119">8301365</NlmUniqueID>
            <ISSNLinking gate:gateId="120">0735-1097</ISSNLinking></MedlineJournalInfo>
        
        <ChemicalList gate:gateId="121">
            <Chemical gate:gateId="122">
                <RegistryNumber gate:gateId="123">0</RegistryNumber>
                <NameOfSubstance gate:gateId="124">Immunosuppressive Agents</NameOfSubstance></Chemical>
            
            <Chemical gate:gateId="125">
                <RegistryNumber gate:gateId="126">33069-62-4</RegistryNumber>
                <NameOfSubstance gate:gateId="127">Paclitaxel</NameOfSubstance></Chemical>
            
            <Chemical gate:gateId="128">
                <RegistryNumber gate:gateId="129">53123-88-9</RegistryNumber>
                <NameOfSubstance gate:gateId="130">Sirolimus</NameOfSubstance></Chemical></ChemicalList>
            
        
        <CitationSubset gate:gateId="131">AIM</CitationSubset>
        <CitationSubset gate:gateId="132">IM</CitationSubset>
        <MeshHeadingList gate:gateId="133">
            <MeshHeading gate:gateId="134">
                <DescriptorName gate:gateId="135" MajorTopicYN="N">Aged</DescriptorName></MeshHeading>
            
            <MeshHeading gate:gateId="136">
                <DescriptorName gate:gateId="137" MajorTopicYN="N">Angioplasty, Balloon, Coronary</DescriptorName>
                <QualifierName gate:gateId="138" MajorTopicYN="Y">instrumentation</QualifierName></MeshHeading>
            
            <MeshHeading gate:gateId="139">
                <DescriptorName gate:gateId="140" MajorTopicYN="N">Coronary Angiography</DescriptorName></MeshHeading>
            
            <MeshHeading gate:gateId="141">
                <DescriptorName gate:gateId="142" MajorTopicYN="N">Coronary Artery Disease</DescriptorName>
                <QualifierName gate:gateId="143" MajorTopicYN="N">radiography</QualifierName>
                <QualifierName gate:gateId="144" MajorTopicYN="Y">surgery</QualifierName></MeshHeading>
            
            <MeshHeading gate:gateId="145">
                <DescriptorName gate:gateId="146" MajorTopicYN="N">Death, Sudden, Cardiac</DescriptorName>
                <QualifierName gate:gateId="147" MajorTopicYN="N">epidemiology</QualifierName>
                <QualifierName gate:gateId="148" MajorTopicYN="N">etiology</QualifierName></MeshHeading>
            
            <MeshHeading gate:gateId="149">
                <DescriptorName gate:gateId="150" MajorTopicYN="Y">Drug-Eluting Stents</DescriptorName></MeshHeading>
            
            <MeshHeading gate:gateId="151">
                <DescriptorName gate:gateId="152" MajorTopicYN="N">Female</DescriptorName></MeshHeading>
            
            <MeshHeading gate:gateId="153">
                <DescriptorName gate:gateId="154" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading>
            
            <MeshHeading gate:gateId="155">
                <DescriptorName gate:gateId="156" MajorTopicYN="N">Humans</DescriptorName></MeshHeading>
            
            <MeshHeading gate:gateId="157">
                <DescriptorName gate:gateId="158" MajorTopicYN="N">Immunosuppressive Agents</DescriptorName>
                <QualifierName gate:gateId="159" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading>
            
            <MeshHeading gate:gateId="160">
                <DescriptorName gate:gateId="161" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading>
            
            <MeshHeading gate:gateId="162">
                <DescriptorName gate:gateId="163" Type="Geographic" MajorTopicYN="N">Korea</DescriptorName>
                <QualifierName gate:gateId="164" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading>
            
            <MeshHeading gate:gateId="165">
                <DescriptorName gate:gateId="166" MajorTopicYN="N">Male</DescriptorName></MeshHeading>
            
            <MeshHeading gate:gateId="167">
                <DescriptorName gate:gateId="168" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading>
            
            <MeshHeading gate:gateId="169">
                <DescriptorName gate:gateId="170" MajorTopicYN="N">Myocardial Infarction</DescriptorName>
                <QualifierName gate:gateId="171" MajorTopicYN="N">epidemiology</QualifierName>
                <QualifierName gate:gateId="172" MajorTopicYN="N">etiology</QualifierName></MeshHeading>
            
            <MeshHeading gate:gateId="173">
                <DescriptorName gate:gateId="174" MajorTopicYN="N">Paclitaxel</DescriptorName>
                <QualifierName gate:gateId="175" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading>
            
            <MeshHeading gate:gateId="176">
                <DescriptorName gate:gateId="177" MajorTopicYN="Y">Registries</DescriptorName></MeshHeading>
            
            <MeshHeading gate:gateId="178">
                <DescriptorName gate:gateId="179" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading>
            
            <MeshHeading gate:gateId="180">
                <DescriptorName gate:gateId="181" MajorTopicYN="N">Sirolimus</DescriptorName>
                <QualifierName gate:gateId="182" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading>
            
            <MeshHeading gate:gateId="183">
                <DescriptorName gate:gateId="184" MajorTopicYN="N">Survival Rate</DescriptorName>
                <QualifierName gate:gateId="185" MajorTopicYN="N">trends</QualifierName></MeshHeading>
            
            <MeshHeading gate:gateId="186">
                <DescriptorName gate:gateId="187" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation>
            
        
    
    <PubmedData gate:gateId="188">
        <History gate:gateId="189">
            <PubMedPubDate gate:gateId="190" PubStatus="received">
                <Year gate:gateId="191">2009</Year>
                <Month gate:gateId="192">10</Month>
                <Day gate:gateId="193">15</Day></PubMedPubDate>
            
            <PubMedPubDate gate:gateId="194" PubStatus="revised">
                <Year gate:gateId="195">2010</Year>
                <Month gate:gateId="196">2</Month>
                <Day gate:gateId="197">2</Day></PubMedPubDate>
            
            <PubMedPubDate gate:gateId="198" PubStatus="accepted">
                <Year gate:gateId="199">2010</Year>
                <Month gate:gateId="200">2</Month>
                <Day gate:gateId="201">9</Day></PubMedPubDate>
            
            <PubMedPubDate gate:gateId="202" PubStatus="entrez">
                <Year gate:gateId="203">2010</Year>
                <Month gate:gateId="204">4</Month>
                <Day gate:gateId="205">17</Day>
                <Hour gate:gateId="206">6</Hour>
                <Minute gate:gateId="207">0</Minute></PubMedPubDate>
            
            <PubMedPubDate gate:gateId="208" PubStatus="pubmed">
                <Year gate:gateId="209">2010</Year>
                <Month gate:gateId="210">4</Month>
                <Day gate:gateId="211">17</Day>
                <Hour gate:gateId="212">6</Hour>
                <Minute gate:gateId="213">0</Minute></PubMedPubDate>
            
            <PubMedPubDate gate:gateId="214" PubStatus="medline">
                <Year gate:gateId="215">2010</Year>
                <Month gate:gateId="216">6</Month>
                <Day gate:gateId="217">16</Day>
                <Hour gate:gateId="218">6</Hour>
                <Minute gate:gateId="219">0</Minute></PubMedPubDate></History>
            
        
        <PublicationStatus gate:gateId="220">ppublish</PublicationStatus>
        <ArticleIdList gate:gateId="221">
            <ArticleId gate:gateId="222" IdType="pii">S0735-1097(10)00687-X</ArticleId>
            <ArticleId gate:gateId="223" IdType="doi">10.1016/j.jacc.2010.02.008</ArticleId>
            <ArticleId gate:gateId="224" IdType="pubmed">20394879</ArticleId></ArticleIdList></PubmedData></PubmedArticle>
        
    


</PubmedArticleSet>